Correlation Between Burzynski Research and Innovent Biologics
Can any of the company-specific risk be diversified away by investing in both Burzynski Research and Innovent Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Burzynski Research and Innovent Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Burzynski Research and Innovent Biologics, you can compare the effects of market volatilities on Burzynski Research and Innovent Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Burzynski Research with a short position of Innovent Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Burzynski Research and Innovent Biologics.
Diversification Opportunities for Burzynski Research and Innovent Biologics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Burzynski and Innovent is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Burzynski Research and Innovent Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovent Biologics and Burzynski Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Burzynski Research are associated (or correlated) with Innovent Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovent Biologics has no effect on the direction of Burzynski Research i.e., Burzynski Research and Innovent Biologics go up and down completely randomly.
Pair Corralation between Burzynski Research and Innovent Biologics
Given the investment horizon of 90 days Burzynski Research is expected to generate 4.28 times more return on investment than Innovent Biologics. However, Burzynski Research is 4.28 times more volatile than Innovent Biologics. It trades about 0.06 of its potential returns per unit of risk. Innovent Biologics is currently generating about 0.03 per unit of risk. If you would invest 4.10 in Burzynski Research on September 3, 2024 and sell it today you would lose (0.60) from holding Burzynski Research or give up 14.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.68% |
| Values | Daily Returns |
Burzynski Research vs. Innovent Biologics
Performance |
| Timeline |
| Burzynski Research |
| Innovent Biologics |
Burzynski Research and Innovent Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Burzynski Research and Innovent Biologics
The main advantage of trading using opposite Burzynski Research and Innovent Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Burzynski Research position performs unexpectedly, Innovent Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovent Biologics will offset losses from the drop in Innovent Biologics' long position.| Burzynski Research vs. ProKidney Corp | Burzynski Research vs. Orchestra BioMed Holdings | Burzynski Research vs. Lixte Biotechnology Holdings | Burzynski Research vs. Oncology Pharma |
| Innovent Biologics vs. Telix Pharmaceuticals Limited | Innovent Biologics vs. Keros Therapeutics | Innovent Biologics vs. MAIA Biotechnology | Innovent Biologics vs. Clarity Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |